A new study shows just how strong natural immunity against COVID-19 is for people who have already had the infection.
Researchers from the Institute for Health Metrics and Evaluation COVID-19 Forecasting Team looked at 65 studies from 19 countries.
The Lancet study authors determined people are protected against symptomatic illness for at least 10 months after COVID infection.Researchers say that's about as good as two vaccines.That's in line with what the Food and Drug Administration is loosely encouraging right now, but no vaccine schedule has been set in stone.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Vaccination Could Reduce Risk of Long COVID, Study ShowsA study focusing on fatigue and other long COVID symptoms saw some differences in severity of symptoms based on COVID variants, but these differences became insignificant when researchers accounted for vaccination status. The lead researcher says this discovery suggests that vaccinations may lower the risk of long COVID.
Les mer »
Study shows natural immunity to COVID lasts at least 10 months after infectionA new study shows just how strong natural immunity against COVID-19 is for people who have already had the infection.
Les mer »
Study shows natural immunity to COVID lasts at least 10 months after infectionA new study shows just how strong natural immunity against COVID-19 is for people who have already had the infection.
Les mer »
Study: Kids’ screen time stayed elevated after COVID restrictions endedIncreases in screen time among children persisted more than a year into the pandemic and outlasted COVID-19 restrictions, according to a new study.
Les mer »
Study: Face masks made 'little to no difference' in preventing spread of COVID -SAN DIEGO (KUSI) – Surprise! A new scientific review — led by 12 researchers from esteemed universities around the world — suggests that widespread masking may have done little to nothing to curb the transmission of COVID-19. If you remember, back in April of 2020, the Center for Disease Control (CDC) demanded Americans as young as two-years-old to mask up,...
Les mer »
Paxlovid Doesn’t Increase Risk of Rebound COVID Infection: StudyPeople who took the antiviral Paxlovid to treat COVID-19 infections were not more likely to get back-to-back bouts of the virus, a new study shows.
Les mer »